Xinchang Chen
Shanghai Key Laboratory Of Infectious Diseases And Biosafety Emergency Response
Shanghai, China
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Rifapentine dosing for drug-susceptible tuberculosis: stage 1 of a seamless phase 2/3 randomized clinical trial.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: January 22, 2026
Diagnostic performance of the Sanity 2.0 assay to detect resistance to rifampicin, isoniazid, and fluoroquinolones in tuberculosis.
Journal: Journal of clinical microbiology
Published: December 10, 2025
Acquired resistance during short-course treatment for rifampicin-resistant tuberculosis.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: April 14, 2025
Current drug susceptibility testing in the Löwenstein-Jensen medium leads to underestimating of prothionamide resistance in multi-drug resistant Mycobacterium tuberculosis.
Journal: BMC microbiology
Published: April 04, 2025
A Novel Compound Heterozygous Mutation in the IL12RB1 Gene Causes Susceptibility To Mycobacterium Tilburgii Infection.
Journal: Journal of clinical immunology
Published: January 22, 2025
Mutations in the promoter region of methionine transporter gene metM (Rv3253c) confer para-aminosalicylic acid (PAS) resistance in Mycobacterium tuberculosis.
Journal: mBio
Published: January 05, 2024
Rapid Detection of Extensive Drug Resistance by Xpert MTB/XDR Optimizes Therapeutic Decision-Making in Rifampin-Resistant Tuberculosis Patients.
Journal: Journal of clinical microbiology
Published: May 30, 2023
Optimizing (O) rifapentine-based (RI) regimen and shortening (EN) the treatment of drug-susceptible tuberculosis (T) (ORIENT) using an adaptive seamless design: study protocol of a multicenter randomized controlled trial.
Journal: BMC infectious diseases
Published: April 07, 2023
In vitro Susceptibility of Nontuberculous Mycobacteria to Tedizolid.
Journal: Infection and drug resistance
Published: April 11, 2022
In vitro assessment of 17 antimicrobial agents against clinical Mycobacterium avium complex isolates.
Journal: BMC microbiology
Published: December 05, 2021
Analysis of Serial Multidrug-Resistant Tuberculosis Strains Causing Treatment Failure and Within-Host Evolution by Whole-Genome Sequencing.
Journal: mSphere
Published: December 28, 2020
Last Updated: 09/26/2026